BMC pulmonary medicine
June 23, 2026
1 min readIP Score 10/10
Diagnostic yield and feasibility of EBUS-guided cautery-assisted transbronchial forceps biopsy for suspected benign mediastinal and hilar lymphadenopathy: a prospective self-controlled pilot study.
Lin C; Xue H; Zhou F; Wang D; Li L; Lin X
Abstract
BACKGROUND: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has limited diagnostic yield in benign mediastinal lymphadenopathy. This study aimed to assess the efficacy and safety of EBUS-guided cautery-assisted transbronchial forceps biopsy (EBUS-ca-TBFB), a technique that utilizes an electrocautery knife to create a tunneling tract at the prior TBNA site, for the diagnosis of benign mediastinal and hilar lymphadenopathy. METHODS: In this prospective, self-controlled cohort study, 14 adult patients with unexplained mediastinal or hilar lymphadenopathy clinically suspected to be benign after routine clinical, radiological, and available laboratory evaluation were consecutively enrolled between February 2023 and December 2024. Each patient underwent EBUS-TBNA followed by EBUS-ca-TBFB at the same target nodal station whenever feasible. The diagnostic yield, sensitivity, accuracy, and safety profiles of both techniques were compared. RESULTS: At the patient level, the diagnostic yield of EBUS-ca-TBFB was significantly higher than that of EBUS-TBNA (85.7% [12/14] vs. 21.4% [3/14], P < 0.001). At the lesion level, yields were also higher with EBUS-ca-TBFB (81.3% [13/16] vs. 15.0% [3/20], P < 0.001). Sensitivity and overall accuracy were notably improved with EBUS-ca-TBFB (92.3% vs. 23.1% and 92.9% vs. 28.6%, respectively). No severe complications, such as significant bleeding, pneumothorax, or infection, were observed in any patient. CONCLUSIONS: In this small prospective self-controlled pilot cohort, EBUS-ca-TBFB appeared to provide additional histological diagnostic value after conventional EBUS-TBNA in selected patients with suspected benign mediastinal or hilar lymphadenopathy. No severe procedure-related complications were observed. However, given the small sample size and single-center design, the diagnostic benefit and safety profile of this technique require confirmation in larger multicenter studies.
This case highlights the diagnostic and management challenges of refractory multisystem sarcoidosis progressing over a two-year period despite advanced biologic therapy.
Clinicians should note that the presence of targetable mutations in non-small cell lung cancer with malignant pleural disease is not associated with improved survival, based on the findings from this study.
Shape-sensing robotic-assisted bronchoscopy achieved a strict diagnostic yield of 70.2% with a low pneumothorax rate of 3.3%, demonstrating that earlier tissue diagnosis of very small pulmonary nodules is feasible and safe for clinical practice.
Up nextJournal of Thoracic DiseaseOct 30, 2026Read
This study introduces ultrasound-guided trans-cannula cryobiopsy of supraclavicular lymph nodes as a novel superficial lymph node approach for tissue acquisition in 10 consecutive patients, though specific numeric success or safety results were not provided in the abstract.
Active infection is not an absolute contraindication to endobronchial valve placement, but positive pressure ventilation significantly increases clinical failure odds with an aOR of 3.00 at P < 0.001.